Evidence map›Paper›PMID 29288572›Full record

ReviewJournal of biomedical optics2017

Label-free optical imaging technologies for rapid translation and use during intraoperative surgical and tumor margin assessment.

Stephen A Boppart, J Quincy Brown, Camile S Farah, Esther Kho, Laura Marcu, Christobel M Saunders, Henricus J C M Sterenborg

Abstract readReview
In one paragraph

Review in Journal of biomedical optics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Harnessing non-destructive 3D pathology.Nature biomedical engineering · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stephen A BoppartUniversity of Illinois at Urbana-Champaign, Beckman Institute for Advanced Science and Technology, U, United States.
J Quincy BrownTulane University, Department of Biomedical Engineering, New Orleans, Louisiana, United States.
Camile S FarahUniversity of Western Australia, UWA Dental School, Oral Health Centre of Western Australia, Discipl, Australia.
Esther KhoNetherlands Cancer Institute, Department of Surgery, Amsterdam, The Netherlands.
Laura MarcuUniversity of California-Davis, Department of Biomedical Engineering, Comprehensive Cancer Center, D, United States.
Christobel M SaundersThe University of Western Australia, Department of Surgical Oncology, Crawley, Western Australia, Australia.
Henricus J C M SterenborgNetherlands Cancer Institute, Department of Surgery, Amsterdam, The Netherlands.

Funding

Fluorescence Lifetime Imaging/Spectroscopy System For Robotic Cancer Surgery GuidanceR01CA187427 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BIRKELAND, ANDREW CHARLES, MARCU, LAURA · 2014 to 2025
$4.6M
Intraoperative Polarization-Sensitive OCT for Assessing Breast Tumor MarginsR01CA213149 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI BOPPART, STEPHEN A · 2017 to 2021
$2.4M
Optical Amplification Microscopy of Weak Back-Scattered LightR01EB023232 · NIBIB · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI BOPPART, STEPHEN A · 2016 to 2019
$1.8M
Fluorescence lifetime technique for detection of radiation necrosis vs gliomR21CA178578 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MARCU, LAURA · 2014 to 2015
$360k
NCI NIH HHS R01 CA187427NCI NIH HHS R01 CA213149NCI NIH HHS R21 CA178578NIBIB NIH HHS R01 EB023232
6 · The paper itself

Abstract

The biannual International Conference on Biophotonics was recently held on April 30 to May 1, 2017, in Fremantle, Western Australia. This continuing conference series brought together key opinion leaders in biophotonics to present their latest results and, importantly, to participate in discussions on the future of the field and what opportunities exist when we collectively work together for using biophotonics for biological discovery and medical applications. One session in this conference, entitled "Tumor Margin Identification: Critiquing Technologies," challenged invited speakers and attendees to review and critique representative label-free optical imaging technologies and their application for intraoperative assessment and guidance in surgical oncology. We are pleased to share a summary in this outlook paper, with the intent to motivate more research inquiry and investigations, to challenge these and other optical imaging modalities to evaluate and improve performance, to spur translation and adoption, and ultimately, to improve the care and outcomes of patients.

Indexed as

HumansNeoplasmsOptical ImagingSurgery, Computer-Assistedcancer surgerylabel-freeoptical imagingsurgical margins

Identifiers

PMID29288572
PMCPMC5747261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.